Börse am Thursday: What investors should pay attention to

A.A strong start to the German stock market is expected on Thursday. The pre-market X-Dax last noted with 12,971 points almost 50 points above the closing level of the previous evening. The jumps shouldn’t be big, because futures trading on the American S&P 500 index suggests an unchanged start for Wall Street.

The day before it had digested the rejection of the American President Donald Trump to further negotiations on an economic stimulus package, especially since the US Federal Reserve said it thought it was likely that its very loose interest rate policy would be maintained. In Japan, the Nikkei index closed just under 1 percent higher at 23,646 points

The sudden increase in new corona infections in Germany could possibly have a negative impact on more than 4,000 within a day. The calendar contains the trade data from Germany and from the United States the weekly initial jobless claims. Fresenius Medical Care invites you to Markets Day.

In the United States the volume of consumer credit fell surprisingly by $ 7.22 billion in August. Economists had expected an average increase of $ 14 billion. In the previous month, the loan volume had increased by a revised 14.67 (previously 12.25) billion dollars.

The electronics giant Samsung expects operating profit to rise to 12.3 trillion won (9 billion euros) for the past quarter thanks to the rising demand for smartphones and a robust chip business. That would be an increase of 58 percent year-on-year and more than analysts forecast. The interim price gains of more than one percent nevertheless largely melted together in late trading.

Europe’s largest sugar producer Südzucker Thanks to the gains in the specialties business in the first half of the year, consolidated operating profit rose to EUR 129 million from EUR 74 million a year earlier. For the year as a whole, the Management Board confirmed its forecast of sales of 6.9 to 7.2 (previous year: 6.7) billion euros and an operating result of 300 to 400 (116) million euros.

Sales of the Swiss fragrance and flavor manufacturer Givaudan rose in the first nine months by 2.7 percent to 4.79 billion francs (4.44 billion euros). The Symrise rival only publishes profit figures for the first half of the year and at the end of the year.

The drug researcher Evotec and the pharmaceutical company Bristol Myers Squibb expand their alliance to include another approach to Alzheimer’s disease. Evotec will receive a payment of $ 6 million for this.

The London Stock Exchange (LSE) sells the Milan Stock Exchange apparently to a group consisting of the stock exchange operator Euronext, the majority state-owned Italian development bank Cassa Depositi e Prestiti (CDP) and the bank Intesa Sanpaolo, reported the “Börsen-Zeitung”. The purchase price should be 3.75 billion euros. This had already been expected.


Related Articles

Back to top button